王奕欣,美国威斯康星大学麦迪逊分校药物科学专业博士,2026年5月加入深圳理工大学,现任药学院助理教授,博士生导师。累计发表论文38篇,其中以第一、共一或通讯作者发表文章16篇,包括Nature Nanotechnology、Science Advances和PNAS等。研究方向为基于工程化细胞的免疫疗法。
学习经历:
2021-2025威斯康星大学麦迪逊分校,药物科学,博士
2017-2020中国药科大学,药剂学,硕士
2013-2017中国药科大学,药物制剂,学士
工作经历:
2026.5-至今深圳理工大学,药学院,教研助理教授
2021.3-2021.8威斯康星大学麦迪逊分校,研究助理
肿瘤疫苗的功能优化与机制探究;CAR-T细胞疗法减毒增效策略的研发;细胞衍生治疗平台的构建;仿生药物递送系统的设计开发。
1. Z Li#,Y Wang#, F Mo, T Wolter, R Hong, A Barrett, N Richmond, F Liu, Y Chen, X Yang, L Dempsey, Q Hu*. Engineering pyroptotic vesicles as personalized cancer vaccines,Nature Nanotechnology, 2025, 20(8): 1108-1118.
2.Y Wang, W Li, Z Li, F Mo, Y Chen, M Iida, D L Wheeler, Q Hu*. Active recruitment of anti–PD-1–conjugated platelets through tumor-selective thrombosis for enhanced anti-cancer immunotherapy,Science Advances, 2023, 9(13): eadf6854.
3.Y Wang, E Ogunnaike, H Yang, S Yuan, R Hong, A Barrett, E Ebong, B Liu, G Dotti, Q Hu*. Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery,Proceedings of the National Academy of Sciences of the United States of America, 2025, 122(51): e2522020122.
4.Y Wang#, Z Li#, F Mo, T Chen-Mayfield, A Saini, A LaMere, Q Hu*. Chemically engineering cells for precision medicine,Chemical Society Reviews, 2023, 52(3): 1068-1102.
5. Z Li#,Y Wang#, Z Gu*, Q Hu*. Engineering cells for therapy and diagnosis,Nature Reviews Bioengineering, 2024, 2(9): 770-784.
6.Y Wang, Z Li, Y Chen, A Barrett, F Mo, Q Hu*. Nano-STING agonist-decorated microrobots boost innate and adaptive anti-tumor immunity,Nano Research, 2023, 16(7): 9848-9858.
7.Y Wang, T Chen-Mayfield, Z Li, M Younis, W Cai*, Q Hu*. Harnessing DNA for immunotherapy: Cancer, infectious diseases, and beyond,Advanced Functional Materials, 2022, 32(37): 2112273.
8.Y Wang#, J Liu#, S Yuan, Y You, Q Hu*. Double-layer probiotic encapsulation for enhanced bacteriotherapy against inflammatory bowel disease,Nano Research, 2024, 17(10): 9103-9110.
9.Y Wang, Z Li, F Mo, Z Gu*, Q Hu*. Engineered platelets: Advocates for tumor immunotherapy,Nano Today, 2021, 40: 101281.
10. Z Li#,Y Wang#, Y Ding, L Repp, G Kwon, Q Hu*. Cell-based delivery systems: Emerging carriers for immunotherapy,Advanced Functional Materials, 2021, 31(23): 2100088.
电子邮箱:wang.yixin@suat-sz.edu.cn